List view / Grid view
3 April 2017 | By Dr David Pugh, IDTechEx
The latest 2017 pipelines explores new emerging methods of glucose monitoring, analysing these technologies in the new report from IDTechEx Research...
30 March 2017 | By Pasi Kemppainen, Executive Consultant, Pharma Serialisation and Traceability
Pharma serialisation expert, Pasi Kemppainen, gives us his insights on how serialisation reconciliation can ensure product integrity and patient safety...
29 March 2017 | By Niamh Marriott, Junior Editor
We caught up with the CEO & CSO of Panacea for the latest on vaccine immunotherapies - "As a scientist, as long as you are observant and persistent, you may come up with breakthrough discoveries"
28 March 2017 | By Robert Groebel, Vice President of global medical strategy, Veeva
Veeva's Robert Groebel lays out the best practices toward a more coordinated, better healthcare stakeholder experience...
22 March 2017 | By Russ Pimblett, Business Development Manager (Food, Pharmaceutical and Biomedical), FTL
FTL's Russ Pimblett talks us through sealing issues: colour options, materials choices, hygiene concerns and how to be cost effective and safe...
21 March 2017 | By Kaspar van den Dries PhD, Senior Director and Principal Scientist, Solid Dose Development, Patheon
Patheon's Kaspar van den Dries shows the advantages of considering lipid formulation in early development to optimise a molecule’s developability...
15 March 2017 | By Mike Elliott, Vice President, Medical Affairs, Gilead Sciences
We caught up with Gilead’s Mike Elliott to find out the latest in HIV medication and whether a cure is finally within our reach…
8 March 2017 | By Mark Davison, CEO, Blue Sphere Health Ltd
Blue Sphere Health’s CEO, Mark Davison, outlines how to achieve positive return on investment (ROI) from a cost-effective serialisation initiative…
6 March 2017 | By Niamh Marriott, Junior Editor
We’re live at PITTCON 2017! Check this stream for live updates of the event…
1 March 2017 | By Dorothea Wenzel, Senior VP Global Business Franchise Fertility, Merck
We caught up with Merck's Dorothea Wenzel to hear all about the latest in fertility treatments, training and technologies and to find out the truth about infertility...
1 March 2017 | By Niamh Louise Marriott, Digital Editor
This page will be updated as the results from the Cancer Drugs Fund appraisal are announced by The National Institute of Health and Care Excellence (NICE).
A defining characteristic of inhaled drug delivery is variability in the dose received by the patient, as a result of physiology, for example, or the technique applied during use. This variability directly affects clinical outcomes so reducing it to a minimum is an important goal for the industry...
For the pharmaceutical scientist, the journey of an active molecule from the end of its synthetic pathway and crystallisation to its ultimate site of action is a fascinating one, and one that is necessary to understand...
Commercial biomanufacturing dates to thousands of years and the first biological engine, the yeast, continues to be beneficial...
Near-infrared spectroscopy (NIRS) is used by the pharmaceutical industry for a wide variety of applications, including the identification of drug substances, products and raw materials; tablet assays; uniformity of content; water content; solid state form; and process analytical technologies...
